ClinConnect ClinConnect Logo
Search / Trial NCT06347536

Supported Rescue Packs Post-discharge in Chronic Obstructive Pulmonary Disease

Launched by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST · Apr 2, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Copd Exacerbation Hospital Admission Rescue Packs Self Management Support

ClinConnect Summary

This clinical trial is studying a new way to help patients with chronic obstructive pulmonary disease (COPD) who have recently been discharged from the hospital after a worsening of their condition, known as an exacerbation. The aim is to see if providing patients with a "rescue pack" of medications, along with a self-management plan and regular check-ins via phone or text, can reduce the chances of them needing to return to the hospital within 90 days. Researchers hope that this approach will improve patient outcomes and potentially save money for the healthcare system.

To be eligible for the study, participants must be at least 40 years old and have been hospitalized for a COPD exacerbation. They should also be able to give informed consent and manage their own care with some support. Those who may not qualify include individuals needing special breathing support during their hospital stay, patients with serious health issues affecting their survival, or those living in care facilities. If you join the trial, you can expect to receive the rescue pack and self-management tools, along with regular follow-ups to monitor your symptoms and health. Your participation could help improve care for others with COPD in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 40 years
  • Individuals admitted to hospital with COPD exacerbation who have recently been discharged (discharged from ongoing support from secondary care team which includes hospital and virtual wards). Admission is defined as an episode in which a patient with an exacerbation of COPD is admitted to a ward and has stayed in hospital for 4 hours or more, including Emergency Medicine Centres, Medical Admission Units, Clinical Decision Units, short stay wards or similar but excludes patients treated transiently before being discharged from Emergency Department.
  • Ability to provide written informed consent
  • Exclusion Criteria:
  • Individuals who require invasive ventilation during the hospital admission
  • Patients who have an expected survival of less than 90 days
  • Patients with signs of new consolidation on chest X-ray (if available).
  • Individuals who have been discharged to a residential or nursing home to residential or nursing home.
  • Individuals who are unable to manage a supported self-management plan.
  • Individuals with no access to telephone.
  • Individuals who are already taking part in an interventional trial.
  • Previous participation in the RAPID trial.

About Guy's And St Thomas' Nhs Foundation Trust

Guy's and St Thomas' NHS Foundation Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and clinical excellence. As a prominent academic health science center, the Trust integrates cutting-edge research with clinical practice, facilitating the translation of scientific discoveries into improved treatment options. With a diverse portfolio of clinical trials across various medical specialties, Guy's and St Thomas' NHS Foundation Trust plays a pivotal role in advancing healthcare knowledge and enhancing patient outcomes, while maintaining the highest ethical standards in research and patient safety.

Locations

London, , United Kingdom

Leicester, , United Kingdom

London, , United Kingdom

London, , United Kingdom

Blackpool, , United Kingdom

Maidstone, , United Kingdom

London, , United Kingdom

Milton Keynes, , United Kingdom

Bradford, , United Kingdom

Lancaster, , United Kingdom

Newcastle Upon Tyne, , United Kingdom

Oxford, , United Kingdom

Salisbury, , United Kingdom

Slough, , United Kingdom

Stockport, , United Kingdom

Sutton In Ashfield, , United Kingdom

Barnsley, , United Kingdom

Llandough, , United Kingdom

Durham, , United Kingdom

North Shields, , United Kingdom

Stockton On Tees, , United Kingdom

London, , United Kingdom

Whiston, , United Kingdom

Brighton, , United Kingdom

Birmingham, , United Kingdom

Bristol, , United Kingdom

Ipswich, , United Kingdom

Middlesbrough, , United Kingdom

Nottingham, , United Kingdom

Shirley, , United Kingdom

South Shields, , United Kingdom

Taunton, , United Kingdom

Yeovil, , United Kingdom

Gateshead, , United Kingdom

Rotherham, , United Kingdom

Southport, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Mona Bafadhel, Professor

Principal Investigator

King's College London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported